• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2020

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-12-01 15:00
News
IR
English
Corporate Information
Other Corporate Information
First patient in the European Heart Preservation study transplanted
2020-12-01 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i den europeiska hjärtpreservationsstudien har blivit transplanterad
2020-11-20 08:30
News
IR
English
Corporate Information
Other Corporate Information
Publication in The Lancet shows better survival of transplanted kidneys after cold machine perfusion with oxygen
2020-11-20 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
The Lancet publikation visar på bättre överlevnad av transplanterade njurar efter kall maskinperfusion med tillsatt syrgas
2020-10-23 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
First in the world with products for all major solid organs
2020-10-23 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Först i världen med produkter inom samtliga stora organområden
2020-10-16 16:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-10-16 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-10-14 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Extraordinary General Meeting in XVIVO Perfusion
2020-10-14 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från extra bolagsstämma i XVIVO Perfusion
2020-10-01 18:00
News
IR
English
Corporate Action
M&A
XVIVO Perfusion completes the acquisition of Organ Assist B.V.
2020-10-01 18:00
News
IR
Swedish
Corporate Action
M&A
XVIVO Perfusion slutför förvärvet av Organ Assist B.V.
2020-09-30 08:45
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2020-09-30 08:45
News
IR
English
Corporate Information
Nomination Committee
Nomination committee of XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2020-09-24 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusions teckningsoptionsprogram 2020/2022
2020-09-24 07:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion’s warrant program 2020/2022
2020-09-23 23:04
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 2,118,640 shares at a subscription price of SEK 236 per share
2020-09-23 23:04
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 2 118 640 aktier till en teckningskurs om 236 kronor per aktie
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-09-09 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i PrimECC-studien inkluderad
2020-09-09 07:30
News
IR
English
Corporate Information
Other Corporate Information
First patient in the PrimECC study included
2020-09-04 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion stärker ledningsgruppen med ny Commercial Director och ny R&D Director
2020-09-04 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-07-02 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-07-02 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-06-12 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Hjärtpreservations-studien från Lund publicerad i Nature Communications
2020-06-12 16:30
News
IR
English
Corporate Information
Other Corporate Information
The study from Lund published in Nature Communications
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ säljs till en ledande lungtransplantationsklinik i Europa
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ sold to a leading lung transplant clinic in Europe
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO utnämner ny IP-chef och ny Medicinsk chef
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO appoints a new IP manager and a new Medical Director
2020-04-09 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Strong cash flow despite the influence of Covid-19
2020-04-09 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Starkt kassaflöde trots påverkan av Covid-19
2020-04-06 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport (uppdaterad länk)
2020-04-06 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report (link updated)
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-03-31 17:00
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2020-03-31 17:00
News
IR
English
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2020-03-31 09:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ såld till pediatrisk transplantationsklinik i Italien
2020-03-31 09:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ sold to pediatric transplantation clinic in Italy
2020-03-25 10:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden – justerad version
2020-03-25 10:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration -adjusted version
2020-03-25 10:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration
2020-03-25 10:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden
2020-03-25 08:30
News
IR
English
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion advances the date for submission of the January-March 2020 interim report
2020-03-25 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för avlämnande av delårsrapport för Januari-Mars 2020
2020-03-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Med anledning av Covid-19: XVIVO Perfusion AB:s årsstämma flyttas till ny adress och ytterligare försiktighetsåtgärder vidtas
2020-03-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
As a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are taken
2020-03-18 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
COVID-19 EPIDEMINS PÅVERKAN PÅ XVIVO PERFUSION
2020-03-18 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
THE COVID-19 EFFECT ON XVIVO PERFUSION
2020-03-09 09:00
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2019
2020-03-09 09:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2019
2020-02-24 23:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)
2020-02-24 23:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2020-01-30 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
A historic year ended with a quarter of sales records
2020-01-30 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Kvartal med försäljningsrekord avslutar ett historiskt år
2020-01-24 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2020-01-24 08:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-10-23 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
First in the world with products for all major solid organs
2020-10-23 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Först i världen med produkter inom samtliga stora organområden
2020-10-14 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Extraordinary General Meeting in XVIVO Perfusion
2020-10-14 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från extra bolagsstämma i XVIVO Perfusion
2020-09-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2020-09-23 23:04
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 2,118,640 shares at a subscription price of SEK 236 per share
2020-09-23 23:04
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 2 118 640 aktier till en teckningskurs om 236 kronor per aktie
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve